A5085737900- Acute Myocardial Infarction Research
- Coronary Interventions and Diagnostics
- Heart Failure Treatment and Management
- Coronary Artery Anomalies
- Pulmonary Hypertension Research and Treatments
- Cardiac Imaging and Diagnostics
- Healthcare Systems and Practices
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrest and Resuscitation
- Congenital Heart Disease Studies
- Antiplatelet Therapy and Cardiovascular Diseases
- Pneumocystis jirovecii pneumonia detection and treatment
- Cardiovascular Issues in Pregnancy
- Hormonal Regulation and Hypertension
- Cardiovascular Conditions and Treatments
- Kawasaki Disease and Coronary Complications
- Cardiac Arrhythmias and Treatments
- Immunodeficiency and Autoimmune Disorders
- Emergency and Acute Care Studies
- Peripheral Artery Disease Management
- Peroxisome Proliferator-Activated Receptors
- Tracheal and airway disorders
- COVID-19 and healthcare impacts
- Cardiac Structural Anomalies and Repair
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Centre Hospitalier Départemental Vendée
2014-2023
Roche (France)
2013-2022
British Heart Foundation
2022
University of Leeds
2022
Hôpital Bichat-Claude-Bernard
2021
Assistance Publique – Hôpitaux de Paris
2021
La Roche College
2014
Centre Hospitalier Universitaire de Nantes
2006
Institut du Thorax
2005-2006
Introduction TBX4 mutation causes small patella syndrome (SPS) and/or pulmonary arterial hypertension (PAH). The characteristics and outcomes of PAH associated with mutations are largely unknown. Methods We report the clinical, functional, radiologic, histologic haemodynamic heritable patients carrying a from French (PH) network. Results 20 were identified in 17 families. They characterised by median age at diagnosis 29 years (0–76 years) female to male ratio three. Most (70%) New York Heart...
The aim of this study was to assess the impact coronavirus disease 2019 (COVID-19) outbreak on incidence, delays, and outcomes ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PPCI) in France.We analyzed all PPCI <24 hours STEMI included prospective France PCI registry. 2 groups were compared mean monthly number patients, delays pathway care, in-hospital major adverse cardiac events (MACE: death, stent thrombosis, infarction,...
Abstract Objectives To evaluate the rate of procedural success and long‐term outcomes PK Papyrus (PKP) covered stent (CS). Background CS are essential in treatment coronary artery perforation (CAP). They have also been used to treat aneurysms. Limited evidence is available on clinical with PKP. Methods This was a multicenter, observational, retrospective, prospective study. Consecutive patients undergoing intentional PKP implantation 22 centers France were included. The primary endpoint...
Background With the emergence of coronary computed tomography (CT) angiography, anomalous aortic origin a artery (ANOCOR) is more frequently diagnosed. Fractional flow reserve derived from CT (FFRCT) noninvasive functional test providing anatomical and evaluation overall tree. These unique features could help for management patients with ANOCOR. We aimed to retrospectively evaluate physiological clinical impact FFRCT analysis in ANOCOR registry population. Methods Results The included...
Early mortality post-ST-segment elevation myocardial infarction (STEMI) in France remains high. The multicentre Percutaneous Coronary Intervention Registry includes every patient undergoing coronary angiography France. We analyzed the prevalence and impact of unmodifiable modifiable risk factors on 30-day survival patients experiencing STEMI. Patients admitted for STEMI between 01/2014 12/2016 were included analysis. with nonobstructive artery disease, cardiogenic shock or cardiac arrest...